COMMUNIQUÉS West-GlobeNewswire

-
BioAdaptives, Inc. Announces 5 Unique Products Ready for Phased Entry Into the Nutritional Marketplace
22/11/2024 -
Notice of AGM
22/11/2024 -
Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event
22/11/2024 -
Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C
21/11/2024 -
BioXcel Therapeutics Announces Proposed Public Offering
21/11/2024 -
High Haven Celebrates "Danksgiving" Cannabis Event with Green Wednesday and Holiday Deals Across Illinois Locations
21/11/2024 -
Teladoc Health to Participate in Upcoming Investor Conference
21/11/2024 -
BioAge Labs to Present at Upcoming Investor Conferences
21/11/2024 -
Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024
21/11/2024 -
Lifecore Biomedical Hosts Virtual Investor Day
21/11/2024 -
BrightSpring Health Services, Inc. to Participate in Two Upcoming Investor Conferences
21/11/2024 -
Replimune Receives Breakthrough Therapy Designation for RP1 and Submits RP1 Biologics License Application to the FDA under the Accelerated Approval Pathway
21/11/2024 -
Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
21/11/2024 -
CAMP4 Reports Third Quarter 2024 Financial Results
21/11/2024 -
Korro to Participate in Upcoming Investor Conferences
21/11/2024 -
Inventiva reports 2024 Third Quarter Financial Information¹
21/11/2024 -
Inventiva publie ses informations financières du 3ème trimestre 2024¹
21/11/2024 -
Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value
21/11/2024 -
Grant of Restricted Stock Units and Warrants to Employees in Genmab
21/11/2024
Pages